Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin

Journal of Dermatological Science

Volumn 38, Issue 3, 2005, Pages 177-188

  Ständer, Sonja ^a   Schmelz, Martin ^b   Metze, Dieter ^a   Luger, Thomas ^a   Rukwied, Roman ^b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cannabinoid receptors; Cutaneous nerve fibers; Human skin; Itch; Nociception

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR;

ARTICLE; CONTROLLED STUDY; HAIR FOLLICLE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MACROPHAGE; MAST CELL; MASTOCYTOSIS; NERVE FIBER; PEPTIDERGIC NERVOUS SYSTEM; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR OCCUPANCY; SEBACEOUS GLAND; SENSORY NERVE CELL; SKIN EPITHELIUM; SKIN NERVE; SKIN RECEPTOR; SKIN STRUCTURE; SWEAT GLAND;

ANIMALS; ECCRINE GLANDS; HAIR FOLLICLE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MACROPHAGES; MAST CELLS; MASTOCYTOSIS, CUTANEOUS; NERVE FIBERS; NEURONS, AFFERENT; RATS; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; SEBACEOUS GLANDS; SKIN; TISSUE DISTRIBUTION;

EID: 20044386244     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2005.01.007     Document Type: Article

References (74)

1. W.A. Devane, F.A. Dysarz III, M.R. Johnson, L.S. Melvin, and A.C. Howlett Determination and characterization of a cannabinoid receptor in rat brain Mol Pharmacol 34 1988 605 613
2. L.A. Matsuda, S.J. Lolait, M.J. Brownstein, A.C. Young, and T.I. Bonner Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 1990 561 564
3. W.P. Farquhar-Smith, M. Egertova, E.J. Bradbury, S.B. McMahon, A.S.C. Rice, and M.R. Elphick Cannabinoid CB1 receptor expression in rat spinal cord Mol. Cellular Neurosci. 15 2000 510 521
4. R. Mechoulam, E. Fride, and V. Di Marzo Endocannabinoids Eur. J. Pharmacol. 359 1998 1 18
5. V. Di Marzo, T. Bisogno, L. De Petrocellis, D. Melck, and B.R. Martin Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids Curr Med Chem 6 1999 721 744
6. B.R. Martin, D.R. Compton, B.F. Thomas, W.R. Prescott, P.J. Little, and R.K. Razdan Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs Pharmacol Biochem Behav 40 1991 471 478
7. J. Harris, L.J. Drew, and V. Chapman Spinal anandamide inhibits nociceptive transmission via cannabinoid receptor activation in vivo NeuroReport 11 2000 2817 2819
8. E.A. Stein, S.A. Fuller, W.S. Edgemond, and W.B. Campbell Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat Br J Pharmacol 119 1996 107 114
9. P.B. Smith, D.R. Compton, S.P. Welch, R.K. Razdan, R. Mechoulam, and B.R. Martin The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice J Pharmacol Exp Ther 270 1994 219 227
10. J.N. Crawley, R.L. Corwin, J.K. Robinson, C.C. Felder, W.A. Devane, and J. Axelrod Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents Pharmacol Biochem Behav 46 1993 967 972
11. L.M. Johanek, and D.A. Simone Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury Pain 109 2004 432 442
12. R. Rukwied, A. Watkinson, F. McGlone, and M. Dvorak Cannabinoid agonists attenuate capsaicin-induced responses in human skin Pain 102 2003 283 288
13. P.M. Zygmunt, J. Petersson, D.A. Andersson, H. Chuang, M. Sorgard, and V. Di Marzo Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide Nature 400 1999 452 457
14. S.E. Jordt, D.M. Bautista, H.H. Chuang, D.D. McKemy, P.M. Zygmunt, and E.D. Hogestatt Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1 Nature 427 2004 260 265
15. I.B. Adams, D.R. Compton, and B.R. Martin Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain J Pharmacol Exp Ther 284 1998 1209 1217
16. V. Di Marzo, C.S. Breivogel, Q. Tao, D.T. Bridgen, R.K. Razdan, and A.M. Zimmer Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain J Neurochem 75 2000 2434 2444
17. M. Bouaboula, M. Rinaldi, P. Carayon, C. Carillon, B. Delpech, and D. Shire Cannabinoid-receptor expression in human leukocytes Eur J Biochem 214 1993 173 180
18. R.G. Pertwee Evidence for the presence of CB1 cannabinoid receptors on peripheral neurones and for the existence of neuronal non-CB1 cannabinoid receptors Life Sci 65 1999 597 605
19. S. Munro, K.L. Thomas, and M. Abu-Shaar Molecular characterization of a peripheral receptor for cannabinoids Nature 365 1993 61 65
20. L.A. Matsuda Molecular aspects of cannabinoid receptors Crit Rev Neurobiol 11 1997 143 166
21. S. Galiegue, S. Mary, J. Marchand, D. Dussossoy, D. Carriere, and P. Carayon Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations Eur J Biochem 232 1995 54 61
22. T.W. Klein, C. Newton, K. Larsen, L. Lu, I. Perkins, and L. Nong The cannabinoid system and immune modulation J Leukoc Biol 74 2003 486 496
23. A. Arevalo-Martin, J.M. Vela, E. Molina-Holgado, J. Borrell, and C. Guaza Therapeutic action of cannabinoids in a murine model of multiple sclerosis J Neurosci 23 2003 2511 2516
24. J. Killestein, E.L. Hoogervorst, M. Reif, N.F. Kalkers, A.C. Van Loenen, and P.G. Staats Safety, tolerability, and efficacy of orally administered cannabinoids in MS Neurology 58 2002 1404 1407
25. D.I. Abrams, J.F. Hilton, R.J. Leiser, S.B. Shade, T.A. Elbeik, and F.T. Aweeka Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial Ann Intern Med 139 2003 258 266
26. D. Baker, and G. Pryce The therapeutic potential of cannabis in multiple sclerosis Expert Opin Investig Drugs 12 2003 561 567
27. M.L. Casanova, C. Blazquez, J. Martinez-Palacio, C. Villanueva, M.J. Fernandez-Acenero, and J.W. Huffman Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors J Clin Invest 111 2003 43 50
28. J. Liu, B. Gao, F. Mirshahi, A.J. Sanyal, A.D. Khanolkar, and A. Makriyannis Functional CB1 cannabinoid receptors in human vascular endothelial cells Biochem J 346 Pt 3 2000 835 840
29. M. Maccarrone, L. De Petrocellis, M. Bari, F. Fezza, S. Salvati, and M.V. Di Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes Arch Biochem Biophys 393 2001 321
30. C. Benito, E. Nunez, R.M. Tolon, E.J. Carrier, A. Rabano, and C.J. Hillard Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains J Neurosci 23 2003 11136 11141
31. M. Maccarrone, M. Di Rienzo, N. Battista, V. Gasperi, P. Guerrieri, and A. Rossi The endocannabinoid system in human keratinocytes: Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activating protein-1, and transglutaminase J Biol Chem 278 2003 33896 33903
32. G. Griffin, S.R. Fernando, R.A. Ross, N.G. McKay, M.L. Ashford, and D. Shire Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals Eur J Pharmacol 339 1997 53 61
33. L. Ruiz-Llorente, M.G. Sanchez, M.J. Carmena, J.C. Prieto, M. Sanchez-Chapado, and A. Izquierdo Expression of functionally active cannabinoid receptor CB1 in the human prostate gland Prostate 54 2003 95 102
34. A.J. Straiker, G. Maguire, K. Mackie, and J. Lindsey Localization of cannabinoid CB1 receptors in the human anterior eye and retina Invest Ophthalmol Vis Sci 40 1999 2442 2448
35. I. Katona, E.A. Rancz, L. Acsady, C. Ledent, K. Mackie, and N. Hajos Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission J Neurosci 21 2001 9506 9518
36. M. Egertova, and M.R. Elphick Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB J Comp Neurol 422 2000 159 171
37. G. Marsicano, and B. Lutz Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain Eur J Neurosci 11 1999 4213 4225
38. T.M. Westlake, A.C. Howlett, T.I. Bonner, L.A. Matsuda, and M. Herkenham Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains Neuroscience 63 1994 637 652
39. M. Herkenham, A.B. Lynn, M.D. Little, M. Ross Johnson, L.S. Melvin, and B.R. De Costa Cannabinoid receptor localization in brain Proc Natl Acad Sci USA 87 1990 1932 1936
40. G. Marsicano, C.T. Wotjak, S.C. Azad, T. Bisogno, G. Rammes, and M.G. Cascio The endogenous cannabinoid system controls extinction of aversive memories Nature 418 2002 530 534
41. M. Martin, C. Ledent, M. Parmentier, R. Maldonado, and O. Valverde Involvement of CB1 cannabinoid receptors in emotional behaviour Psychopharmacology (Berl) 159 2002 379 387
42. D. Bridges, A.S. Rice, M. Egertova, M.R. Elphick, J. Winter, and G.J. Michael Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry Neuroscience 119 2003 803 812
43. A.G. Hohmann, E.M. Briley, and M. Herkenham Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord Brain Res 822 1999 17 25
44. J. Ahluwalia, L. Urban, M. Capogna, S. Bevan, and I. Nagy Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons Neuroscience 100 2000 685 688
45. J. Zhang, C. Hoffert, H.K. Vu, T. Groblewski, S. Ahmad, and D. O'Donnell Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models Eur J Neurosci 17 2003 2750 2754
46. A. Calignano, G. La Rana, A. Giuffrida, and D. Piomelli Control of pain initiation by endogenous cannabinoids Nature 394 1998 277 281
47. A. Dogrul, L.R. Gardell, S. Ma, M.H. Ossipov, F. Porreca, and J. Lai 'Knock-down' of spinal CB1 receptors produces abnormal pain and elevates spinal dynorphin content in mice Pain 100 2002 203 209
48. L.J. Drew, J. Harris, P.J. Millns, D.A. Kendall, and V. Chapman Activation of spinal cannabinoid 1 receptors inhibits C-fibre driven hyperexcitable neuronal responses and increases [35S]GTPgammaS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats Eur J Neurosci 12 2000 2079 2086
49. S. Conti, B. Costa, M. Colleoni, D. Parolaro, and G. Giagnoni Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat Br J Pharmacol 135 2002 181 187
50. T.P. Malan, M.M. Ibrahim, T.W. Vanderah, A. Makriyannis, and F. Porreca Inhibition of pain responses by activation of CB(2) cannabinoid receptors Chem Phys Lipids 121 2002 191 200
51. A.G. Nackley, A. Makriyannis, and A.G. Hohmann Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation Neuroscience 119 2003 747 757
52. A. Dogrul, H. Gul, A. Akar, O. Yildiz, F. Bilgin, and E. Guzeldemir Topical cannabinoid antinociception: synergy with spinal sites Pain 105 2003 11 16
53. O. Yesilyurt, A. Dogrul, H. Gul, M. Seyrek, O. Kusmez, and Y. Ozkan Topical cannabinoid enhances topical morphine antinociception Pain 105 2003 303 308
54. D. Bridges, K. Ahmad, and A.S. Rice The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain Br J Pharmacol 133 2001 586 594
55. J.D. Richardson, S. Kilo, and K.M. Hargreaves Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors Pain 75 1998 111 119
56. H.C. Ellington, M.A. Cotter, N.E. Cameron, and R.A. Ross The effect of cannabinoids on capsaicin-evoked calcitonin gene-related peptide (CGRP) release from the isolated paw skin of diabetic and non-diabetic rats Neuropharmacology 42 2002 966 975
57. C. Weidner, M. Klede, R. Rukwied, G. Lischetzki, U. Neisius, and P.S. Skov Acute effects of substance P and calcitonin gene-related peptide in human skin - a microdialysis study J Invest Dermatol 115 2000 1015 1020
58. M. Schmelz, O. Luz, B. Averbeck, and A. Bickel Plasma extravasation and neuropeptide release in human skin as measured by intradermal microdialysis Neurosci Lett 230 1997 117 120
59. M. Dvorak, A. Watkinson, F. McGlone, and R. Rukwied Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin Inflamm Res 52 2003 238 245
60. S. Kelly, M.D. Jhaveri, D.R. Sagar, D.A. Kendall, and V. Chapman Activation of peripheral cannabinoid CB1 receptors inhibits mechanically evoked responses of spinal neurons in noninflamed rats and rats with hindpaw inflammation Eur J Neurosci 18 2003 2239 2243
61. G.W. Neff, C.B. O'Brien, K.R. Reddy, N.V. Bergasa, A. Regev, and E. Molina Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease Am J Gastroenterol 97 2002 2117 2119
62. L.J. Kehl, D.T. Hamamoto, P.W. Wacnik, D.L. Croft, B.D. Norsted, and G.L. Wilcox A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain Pain 103 2003 175 186
63. M.M. Ibrahim, H. Deng, A. Zvonok, D.A. Cockayne, J. Kwan, and H.P. Mata Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS Proc Natl Acad Sci USA 2003
64. T.P. Malan, M.M. Ibrahim, H.F. Deng, Q. Liu, H.P. Mata, and T. Vanderah CB2 cannabinoid receptor-mediated peripheral antinociception Pain 93 2001 239 245
65. A. Quartilho, H.P. Mata, M.M. Ibrahim, T.W. Vanderah, F. Porreca, and A. Makriyannis Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors Anesthesiology 99 2003 955 960
66. N.E. Kaminski, M.E. Abood, F.K. Kessler, B.R. Martin, and A.R. Schatz Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation Mol Pharmacol 42 1992 736 742
67. S.J. Carlisle, F. Marciano-Cabral, A. Staab, C. Ludwick, and G.A. Cabral Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation Int Immunopharmacol 2 2002 69 82
68. C. Blazquez, M.L. Casanova, A. Planas, T.G. del Pulgar, C. Villanueva, and M.J. Fernandez-Acenero Inhibition of tumor angiogenesis by cannabinoids FASEB J 17 2003 529 531
69. I. Galve-Roperh, C. Sanchez, M.L. Cortes, T.G. del Pulgar, M. Izquierdo, and M. Guzman Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation Nat Med 6 2000 313 319
70. C. Sanchez, M.L. de Ceballos, T.G. del Pulgar, D. Rueda, C. Corbacho, and G. Velasco Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor Cancer Res 61 2001 5784 5789
71. C. Leterrier, D. Bonnard, D. Carrel, J. Rossier, and Z. Lenkei Constitutive endocytic cycle of the CB1 cannabinoid receptor J Biol Chem 279 2004 36013 36021
72. R.S. Martin, L.A. Luong, N.J. Welsh, R.M. Eglen, G.R. Martin, and S.J. MacLennan Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human Br J Pharmacol 129 2000 1707 1715
73. M. Toyoda, M. Nakamura, and M. Morohashi Neuropeptides and sebaceous glands Eur J Dermatol 12 2002 422 427
74. L. Facci, R. Dal Toso, S. Romanello, A. Buriani, S.D. Skaper, and A. Leon Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide Proc Natl Acad Sci USA 92 1995 3376 3380